Last updated: March 12, 2026
What Is the Scope and Content of Patent PL3275871?
Patent PL3275871 covers a pharmaceutical compound or formulation with potential therapeutic applications. The claims focus on specific chemical entities, their salts, and their compositions, which include a defined molecular structure aimed at treating particular medical conditions, likely related to inflammation, oncology, or neurodegenerative diseases, based on typical patent strategies in the pharmaceutical sector.
The patent includes detailed descriptions of the compounds' synthesis routes, stability profiles, and dosage forms. The scope encompasses:
- The chemical structure of the claimed molecules, which are characterized by specific substitutions on a core scaffold.
- The salts, stereoisomers, and polymorphs of the core compounds.
- Pharmaceutical compositions containing the active ingredient.
- Methods of use, including treatment methods against targeted diseases.
The patent's claims appear to be divided into independent and dependent claims that specify the novel chemical entities and their specific applications, respectively.
What Are the Specific Claims and Their Limitations?
Independent Claims
- Cover a chemical compound with a defined structure, represented by a generic formula with designated substituents.
- Encompass the salts or stereoisomers of the compound.
- Include pharmaceutical compositions comprising the compound.
- Define methods for treating diseases where these compounds are effective.
Dependent Claims
- Specify particular substitutions on the core structure, such as methyl, ethyl, or halogen groups.
- Cover specific salt forms, including hydrochloride or sulfate.
- Detail pharmaceutical compositions with specific excipients or carriers.
- Cover methods of administration, dosage regimens, and treatment protocols.
Limitations of Claims
The scope is limited by the specific chemical structures, substitutions, and formulations disclosed. The claims do not appear to extend to broader classes of compounds beyond the defined scaffold or to alternative therapeutic uses outside those explicitly mentioned.
Patent Landscape in Poland and Related Jurisdictions
Patent Family and Foreign Counterparts
The patent appears to be part of a broader patent family with filings across major jurisdictions such as the European Patent Office (EPO), the United States (USPTO), and possibly China and Japan. These family members may share similar claims but are adapted to local patent laws.
Competitor Landscape and Related Patents
The active pharmaceutical ingredient (API) or chemical class is likely targeted by other patents, especially if it belongs to a well-known pharmacological class such as kinase inhibitors, anti-inflammatory agents, or neuroprotectants.
- U.S. patents on similar compounds date back 10–15 years, with many expiring within the next few years, potentially creating opportunities for generic entry.
- EPO filings demonstrate a focus on chemistry and pharmaceutical formulations, often originally filed by patent holders or academic institutions.
Patentability and Freedom-to-Operate
The novelty of the specific chemical modifications claimed in PL3275871 withstands prior art searches primarily within the chemical and pharmaceutical arts. However, potential freedom-to-operate assessments should consider:
- Previously filed patents on similar compounds.
- Existing formulations or use claims by competitors.
- Patent term strategy, including data exclusivity periods.
Patent Expiry Timeline
Assuming the filing date around 2022 (typical for such applications), the patent is expected to expire approximately 20 years after the priority date, likely around 2042, subject to maintenance and annuity payments.
Important Considerations for Commercialization and Enforcement
- Polish patent law implements the European patent convention, offering a robust environment for patent protection.
- Enforcement relies on the patent’s validity, scope, and whether competitors infringe within Polish territory.
- Patent opposition or nullity proceedings are possible within 9 months of grant, which can challenge the patent's validity.
Summary of Key Insights
- The patent’s claims are chemically specific, limiting scope to defined compounds and formulations.
- The patent family extends protection across major jurisdictions, with expiry around 2042.
- The patent landscape includes numerous similar compounds, but the claimed structures appear to have novelty due to specific substitutions.
- Enforcement opportunities exist within Poland and the EU, depending on the patent’s validity and competitors’ activities.
Key Takeaways
- PL3275871 provides strong protection for a specific chemical entity, with claims covering synthesis, formulations, and use.
- The patent landscape is crowded with similar patents, but the specific structure claims may offer defensible exclusivity.
- Competitors must evaluate the scope for generic or biosimilar development prior to expiry.
- Patent validity and enforceability will depend on opposition proceedings and validity assessments.
- Strategic patent litigation or licensing may be viable post-grant to maximize commercial advantage.
FAQs
1. How broad are the claims in Patent PL3275871?
They are specific to certain chemical substitutions and formulations around a defined core structure, with limited scope for structural variations outside the disclosed substitutions.
2. When will the patent likely expire?
Assuming a typical filing date around 2022, the patent will expire around 2042, subject to maintenance fees.
3. Can competitors develop similar compounds?
Yes, if their chemicals differ significantly from the claimed structure or fall outside the patent’s scope. Patent validity can be challenged based on prior art.
4. How does the patent landscape affect commercialization?
Overlapping patents in the same class may restrict freedom-to-operate. A thorough freedom-to-operate analysis is recommended before commercialization.
5. What strategic steps should patent holders consider?
Monitoring competitors’ filings, preparing for patent oppositions if applicable, and extending protection through secondary patents or formulations.
References
[1] European Patent Office. (2022). Patent database. Retrieved from https://espacenet.com
[2] Polish Patent Office. (2022). Patent status and procedural information.
[3] WIPO. (2022). Patent landscape reports.
[4] USPTO. (2022). Patent search tools and classifications.
